Hepion Pharmaceuticals, Inc. (HEPA) stock
HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)
Close on Oct 19, 2026Market cap $7.26MP/E –Yield –
Hepion Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Hepion Pharmaceuticals's operating cash flow for the twelve months ending Sep 30, 2026 was -$2.03M. For fiscal 2025 it was -$3.27M. The highest annual figure on record is -$1.36M in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.27M | – |
| FY2024 | Dec 31, 2024 | -$18.22M | – |
| FY2023 | Dec 31, 2023 | -$40.89M | – |
| FY2022 | Dec 31, 2022 | -$34.96M | – |
| FY2021 | Dec 31, 2021 | -$31.22M | – |
| FY2020 | Dec 31, 2020 | -$16.17M | – |
| FY2019 | Dec 31, 2019 | -$7.57M | – |
| FY2017 | Jun 30, 2017 | -$19.17M | – |
| FY2016 | Jun 30, 2016 | -$16.56M | – |
| FY2015 | Jun 30, 2015 | -$9.67M | – |
| FY2014 | Jun 30, 2014 | -$1.36M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | -$881.90K | – |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$1.39M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $578.58K | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$332.78K | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$445.96K | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$1.38M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$1.12M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$1.15M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$2.52M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$10.93M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$3.62M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$9.00M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$11.24M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$12.44M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$8.21M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$4.80M | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$12.53M | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$7.50M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$10.13M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$7.38M | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -$11.32M | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -$5.17M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$7.35M | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -$4.53M | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -$3.85M | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$3.11M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -$4.68M | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -$2.44M | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -$1.80M | – |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -$1.26M | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -$2.06M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$4.25M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$5.22M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$5.34M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$4.38M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -$4.40M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -$3.88M | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | -$5.48M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | -$2.80M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | -$4.34M | – |
See a number that looks wrong?